A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Host CD73 impairs anti-tumor immunity
Tekijät: Salmi M, Jalkanen S
Kustantaja: LANDES BIOSCIENCE
Julkaisuvuosi: 2012
Journal: OncoImmunology
Tietokannassa oleva lehden nimi: ONCOIMMUNOLOGY
Lehden akronyymi: ONCOIMMUNOLOGY
Numero sarjassa: 2
Vuosikerta: 1
Numero: 2
Aloitussivu: 247
Lopetussivu: 248
Sivujen määrä: 2
ISSN: 2162-4011
DOI: https://doi.org/10.4161/onci.1.2.18310
Tiivistelmä
The enzymatic activity of CD73 produces immune-suppressing adenosine. In CD73 deficient hosts, tumor growth and tumor infiltration by Tregs and type 2 immunosuppressive macrophages is reduced. Pharmacological inhibition of CD73 in wild-type mice has similar tumor-suppressing effects. Host CD73 on leukocytes and endothelial cells is thus detrimental for the anti-tumor immunity.
The enzymatic activity of CD73 produces immune-suppressing adenosine. In CD73 deficient hosts, tumor growth and tumor infiltration by Tregs and type 2 immunosuppressive macrophages is reduced. Pharmacological inhibition of CD73 in wild-type mice has similar tumor-suppressing effects. Host CD73 on leukocytes and endothelial cells is thus detrimental for the anti-tumor immunity.